Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

223,891-223,920 of 319,975

filter-aware
32
The slide uses two distinct chart types to show longitudinal dynamics (line chart) and best response (waterfall chart) for the CA-125 biomarker.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
33
The slide uses a dual-axis chart to correlate tumor size (SLD) and biomarker (CA-125) response to the Olvi-Vec intervention.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
34
Includes histological images of patient samples (Pt.#15A-01 and Pt.#15A-11) showing tumor cell elimination and lymphocyte infiltration.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
35
The slide uses histology images and HALO infiltration histograms to demonstrate the mechanism of action and clinical efficacy.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
36
The slide uses a combination of immunological data (ELISPOT) and clinical imaging data (SLD) to show causality between immune response and tumor shrinkage.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
37
The slide uses clinical data (cytokine levels and PD-L1 staining) to support the mechanism of action.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
01
Slide 1
GMS | Results Presentation Deck | 19 slidesGMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · Attention1 hit
02
GMS | Results Presentation Deck | 19 slidesGMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · Attention1 hit
03
Includes a disclaimer regarding non-GAAP metrics at the bottom.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a four-column layout to detail strategic initiatives and recent progress for each.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
05
The slide uses a combination of summary text, callouts for specific financial impacts, and detailed tables for per-day sales and organic growth metrics.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a combination of bar charts for absolute dollar values and line charts for percentage margins.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Includes footnotes detailing reconciliation and definitions.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a table to compare performance metrics across different product lines.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Includes footnotes regarding reconciliation and tax rate definitions.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
GMS | Results Presentation Deck | 19 slidesGMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
11
Includes operational metrics like branch count and net sales per business day.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
12
Includes supplemental cash flow disclosures and a non-GAAP reconciliation for free cash flow.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
13
The table includes a footnote explaining the organic net sales growth calculation.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
14
The table includes a breakdown of adjustments (A-H) with corresponding footnotes on the right.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
15
Includes detailed line-item adjustments (A-J) with corresponding commentary.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
16
Includes footnotes A and B explaining specific adjustments.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
17
Includes a commentary section explaining the nature of the adjustments (A-E).GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
18
Includes footnotes regarding unamortized discounts and deferred financing costs.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
19
GMS | Results Presentation Deck | 19 slidesGMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations 1 hit
01
Slide 1
Includes date and ticker symbol.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context1 hit
02
Immix Biopharma | Investor Presentation Deck | 62 slidesImmix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context1 hit
03
The slide uses a numbered list format to present key value propositions for investors.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context1 hit
04
The slide uses a grid-based layout to categorize team members into three distinct groups: Leadership, Board of Directors, and Scientific Advisory Board.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context1 hit
05
The slide uses a causal-chain framework to link platform capabilities to strategic outcomes.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Situation & Context1 hit